Jefferies upgraded two Canadian cannabis stocks on Thursday and reduced his price target on a third, while remaining most bullish on buy-rated OrganiGram Holdings Inc., which it said is “really starti...
Tag: Botanical/Homeopathic Drugs
Tilray expected to grow sales sequentially but remain in the red
Tilray Inc. will likely grow its sales over the previous quarter but it’s expected to post a net loss when it becomes the first major cannabis company to post quarterly results in 2022 on Monday. Tilr...